Over 2% Of Kentucky Residents Have Prescription For Anti-Obesity Drugs, The Highest Rate In The Nation

For every 1,000 adults in Kentucky, approximately 21 were prescribed a glucagon-like peptide-1 (GLP-1) agonist anti-obesity drug, such as Ozempic for diabetes and obesity or Wegovy, for obesity during 2023. This is the highest rate of any state.

After Kentucky, West Virginia had the next highest prescribing rate, at 18.9 prescriptions dispensed per 1,000. That was followed by Alaska (17.5 per 1,000), Mississippi (16.1), and Louisiana (15.4). Rhode Island had the lowest rate of prescriptions (3.7 per 1,000), followed by Massachusetts (4.0), Wisconsin (4.3), and . . .